Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Tyrosine Phosphatases: Time to End the Stigma
Stephanie M. Stanford, Nunzio Bottini
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 6, pp. 524-540
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Gyrid Nygaard, Gary S. Firestein
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 6, pp. 316-333
Open Access | Times Cited: 602
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Xinrui Yuan, Hong Bu, Jinpei Zhou, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11368-11396
Closed Access | Times Cited: 175
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
Stephanie M. Stanford, Nunzio Bottini
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 273-294
Open Access | Times Cited: 68
Targeting SHP2 as a promising strategy for cancer immunotherapy
Qianqian Liu, Jiao Qu, Mingxia Zhao, et al.
Pharmacological Research (2019) Vol. 152, pp. 104595-104595
Closed Access | Times Cited: 138
A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models
Navasona Krishnan, Konstantis F. Konidaris, Gilles Gasser, et al.
Journal of Biological Chemistry (2017) Vol. 293, Iss. 5, pp. 1517-1525
Open Access | Times Cited: 114
Recent advance on PTP1B inhibitors and their biomedical applications
Bigyan Sharma, Liuxing Xie, Fen Yang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 199, pp. 112376-112376
Closed Access | Times Cited: 112
Turn and Face the Strange: A New View on Phosphatases
Maja Köhn
ACS Central Science (2020) Vol. 6, Iss. 4, pp. 467-477
Open Access | Times Cited: 107
Loop Dynamics and Enzyme Catalysis in Protein Tyrosine Phosphatases
Rory Crean, Michal Biler, Marc W. van der Kamp, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 10, pp. 3830-3845
Open Access | Times Cited: 65
Enzyme Responsive Rigid-Rod Aromatics Target “Undruggable” Phosphatases to Kill Cancer Cells in a Mimetic Bone Microenvironment
Meihui Yi, Fengbin Wang, Weiyi Tan, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 29, pp. 13055-13059
Open Access | Times Cited: 45
A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity
Shuwei Liang, Eric Tran, Xin Du, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38
Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs
Andrea Coronell‐Tovar, Juan Pablo Pardo, Adela Rodríguez‐Romero, et al.
FEBS Letters (2024)
Open Access | Times Cited: 10
The Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein
Niall M. McLoughlin, Carolin Mueller, Tom N. Grossmann
Cell chemical biology (2017) Vol. 25, Iss. 1, pp. 19-29
Open Access | Times Cited: 69
The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders
Robert Roskoski
Pharmacological Research (2018) Vol. 133, pp. 35-52
Closed Access | Times Cited: 69
NRASStatus Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma
Ivette Valencia-Sama, Yagnesh Ladumor, Lynn Kee, et al.
Cancer Research (2020) Vol. 80, Iss. 16, pp. 3413-3423
Open Access | Times Cited: 58
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state
Peter G. Miller, Murugappan Sathappa, Jamie A. Moroco, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Ahmed M.O. Elbatsh, Ali Amin‐Mansour, Anne Haberkorn, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 481-499
Open Access | Times Cited: 6
Off‐target inhibition by active site‐targeting SHP 2 inhibitors
Ryouhei Tsutsumi, Hao Ran, Benjamin G. Neel
FEBS Open Bio (2018) Vol. 8, Iss. 9, pp. 1405-1411
Open Access | Times Cited: 49
The dead phosphatases society: a review of the emerging roles of pseudophosphatases
Veronika Reiterer, Krzysztof Pawłowski, Guillaume Desrochers, et al.
FEBS Journal (2020) Vol. 287, Iss. 19, pp. 4198-4220
Open Access | Times Cited: 40
Controlled Selectivity through Reversible Inhibition of the Catalyst: Stereodivergent Semihydrogenation of Alkynes
Jie Luo, Yaoyu Liang, Michael Montag, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 29, pp. 13266-13275
Open Access | Times Cited: 26
Exploring protein tyrosine phosphatases (PTP) and PTP-1B inhibitors in management of diabetes mellitus
Tapan Behl, Amit Gupta, Aayush Sehgal, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113405-113405
Open Access | Times Cited: 25
Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
Shanelle R. Shillingford, Anton M. Bennett
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 617-636
Open Access | Times Cited: 15
Coupling substrate-trapping with proximity-labeling to identify protein tyrosine phosphatase PTP1B signaling networks
Christopher A Bonham, Vinay Mandati, Rakesh K Singh, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104582-104582
Open Access | Times Cited: 15
Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Jiao Pang, Chang-Qian Cen, Tian Yuan, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
Zhang Li, Yang Luo, Haili Shen
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access
Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer
Naijie Fu, Yuwen Sheng, Zhe Fan, et al.
Advanced Science (2025)
Open Access
Page 1 - Next Page

Scroll to top